Literature DB >> 19797606

Intestinal detoxification limits the activation of hepatic pregnane X receptor by lithocholic acid.

Bryn M Owen1, Alexandra Milona, Saskia van Mil, Peter Clements, Julie Holder, Mohamed Boudjelal, William Cairns, Malcolm Parker, Roger White, Catherine Williamson.   

Abstract

The intestinal-derived secondary bile acid (BA) lithocholic acid (LCA) is hepatotoxic and is implicated in the pathogenesis of cholestatic diseases. LCA is an endogenous ligand of the xenobiotic nuclear receptor pregnane X receptor (PXR), but there is currently no consensus on the respective roles of hepatic and intestinal PXR in mediating protection against LCA in vivo. Under the conditions reported here, we show that mice lacking Pxr are resistant to LCA-mediated hepatotoxicity. This unexpected phenotype is found in association with enhanced urinary BA excretion and elevated basal expression of drug metabolism enzymes and the hepatic sulfate donor synthesis enzyme Papss2 in Pxr(-/-) mice. By subsequently comparing molecular responses to dietary and intraperitoneal administration of LCA, we made two other significant observations: 1) LCA feeding induces intestinal, but not hepatic, drug-metabolizing enzymes in a largely Pxr-independent manner; and 2) in contrast to LCA feeding, bypassing first-pass gut transit by intraperitoneal administration of LCA did induce hepatic detoxification machinery and in a Pxr-dependent manner. These data reconcile important discrepancies in the reported molecular responses to this BA and suggest that Pxr plays only a limited role in mediating responses to gut-derived LCA. Furthermore, the route of administration must be considered in the future planning and interpretation of experiments designed to assess hepatic responses to BAs, orally administered pharmaceuticals, and dietary toxins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19797606      PMCID: PMC2802420          DOI: 10.1124/dmd.109.029306

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  29 in total

1.  Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

Authors:  Peter Fickert; Andrea Fuchsbichler; Hanns-Ulrich Marschall; Martin Wagner; Gernot Zollner; Robert Krause; Kurt Zatloukal; Hartmut Jaeschke; Helmut Denk; Michael Trauner
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 2.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

3.  Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.

Authors:  Catherine A M Stedman; Christopher Liddle; Sally A Coulter; Junichiro Sonoda; Jacqueline G A Alvarez; David D Moore; Ronald M Evans; Michael Downes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

4.  Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR).

Authors:  Junichiro Sonoda; Wen Xie; John M Rosenfeld; Joyce L Barwick; Philip S Guzelian; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

5.  Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis.

Authors:  S Teng; M Piquette-Miller
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

6.  Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.

Authors:  Gernot Zollner; Martin Wagner; Tarek Moustafa; Peter Fickert; Dagmar Silbert; Judith Gumhold; Andrea Fuchsbichler; Emina Halilbasic; Helmut Denk; Hanns-Ulrich Marschall; Michael Trauner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-15       Impact factor: 4.052

Review 7.  Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential.

Authors:  Amazia Zimber; Christian Gespach
Journal:  Anticancer Agents Med Chem       Date:  2008-06       Impact factor: 2.505

Review 8.  Coordinate regulation of gallbladder motor function in the gut-liver axis.

Authors:  Piero Portincasa; Agostino Di Ciaula; Helen H Wang; Giuseppe Palasciano; Karel J van Erpecum; Antonio Moschetta; David Q-H Wang
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

Review 9.  Enzymes in the conversion of cholesterol into bile acids.

Authors:  Maria Norlin; Kjell Wikvall
Journal:  Curr Mol Med       Date:  2007-03       Impact factor: 2.222

Review 10.  Intrahepatic cholestasis of pregnancy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Orphanet J Rare Dis       Date:  2007-05-29       Impact factor: 4.123

View more
  3 in total

Review 1.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

2.  Sulforaphane is not an effective antagonist of the human pregnane X-receptor in vivo.

Authors:  Emma Jane Poulton; Lisa Levy; Johanna W Lampe; Danny D Shen; Julia Tracy; Margaret C Shuhart; Kenneth E Thummel; David L Eaton
Journal:  Toxicol Appl Pharmacol       Date:  2012-11-12       Impact factor: 4.219

3.  Decreased ω-6:ω-3 PUFA ratio attenuates ethanol-induced alterations in intestinal homeostasis, microbiota, and liver injury.

Authors:  Dennis R Warner; Jeffrey B Warner; Josiah E Hardesty; Ying L Song; Taylor N King; Jing X Kang; Chih-Yu Chen; Shanfu Xie; Fang Yuan; Md Aminul Islam Prodhan; Xipeng Ma; Xiang Zhang; Eric C Rouchka; Krishna Rao Maddipati; Joan Whitlock; Eric C Li; Gary P Wang; Craig J McClain; Irina A Kirpich
Journal:  J Lipid Res       Date:  2019-10-04       Impact factor: 5.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.